Harm Reduction Therapeutics (HRT), Inc.
Harm Reduction Therapeutics (HRT), Inc., headquartered in the United States, is a pioneering organisation in the field of harm reduction and public health. Founded in 2018, HRT focuses on developing innovative solutions to address the opioid crisis and other substance use challenges. The company operates primarily across the US, with a commitment to improving health outcomes through evidence-based practices. HRT's core offerings include the development of low-cost, accessible naloxone products, which are essential in reversing opioid overdoses. What sets HRT apart is its dedication to affordability and community accessibility, ensuring that life-saving interventions reach those in need. With a strong market position, HRT has garnered recognition for its impactful contributions to harm reduction, making significant strides in public health advocacy and education.
DitchCarbon Score
How does Harm Reduction Therapeutics (HRT), Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Harm Reduction Therapeutics (HRT), Inc.'s score of 13 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Harm Reduction Therapeutics (HRT), Inc.'s reported carbon emissions
Harm Reduction Therapeutics (HRT), Inc., headquartered in the US, currently does not have any publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. Without specific emissions figures or commitments, it is challenging to assess their carbon footprint or climate strategy. However, the absence of data may indicate an opportunity for HRT to enhance transparency and set measurable climate goals in line with industry standards. As the focus on sustainability and climate action intensifies, establishing clear emissions reduction targets could position HRT favourably within the sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Harm Reduction Therapeutics (HRT), Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
